Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Reexamination Certificate
2003-07-07
2009-11-10
Padmanabhan, Sreeni (Department: 1617)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
C514S908000
Reexamination Certificate
active
07615574
ABSTRACT:
The present invention provides a method of treating acute and chronic myeloid leukemia (AML & CML) and lymphoid leukemia, said method comprising administering a pharmaceutical composition comprising pharmaceutically effective amount of chlorogenic acid (CA) and 3-o-p-Coumaryl quinic acid (PCQ) isolated from any plant parts ofPiper betelor any other source, both individually or in a synergistic combination optionally along with pharmaceutically acceptable additives.
REFERENCES:
patent: 5389371 (1995-02-01), Shiao
patent: 5582822 (1996-12-01), Brandely et al.
patent: 6610332 (2003-08-01), Pal et al.
patent: 401261403 (1989-10-01), None
patent: 09278666 (1997-10-01), None
patent: 10077495 (1998-03-01), None
patent: 11130685 (1999-05-01), None
Dunussi-Joannopoulos et al. (See Attached Copy).
Ferguson (Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis; vol. 475, Issues 1-2, Apr. 18, 2001, pp. 89-111).
Kuroda et al. (Mutation Research/Reviews in Mutation Research vol. 436, Issue 1, Jan. 1999, pp. 69-97).
Yang et al. (Drug Metabolism Reviews, vol. 33, Issue 3 & 4 Dec. 2001 , pp. 237-253).
Wealth of India, vol. 8, pp. 84-95.
Sengupta et al., Indian Journal of Experimental Biology (Apr. 2000), vol. 38, 338-342.
Sadasivan et al., Mutation Research, Chromosome-Damaging Effect of Betel Leaf, (1978), vol. 57, pp. 183-185.
Van De Graaff et al., Concepts of Human Anatomy and Physiology, WCB Publishers, (1986) pp. 159, 618, 706-709.
Database WPI, Section CH, Week 199930, Derwent Publications LTD., London, BG; Class B04, an 1999-352797, XP002174279 (JP 11 130685 A).
Database WPI, Section CH, Week 199702, Derwent Publications Ltd., London, BG; Class B04, AN 1997-017312, XP002174280 (JP 08 283171 A).
Mori H et al., “Carcinogenicity Examination of Betel Nuts and Piper Betel Leaves”, Experientia (1979), vol. 35, No. 3, pp. 384-385. ISSN: 0014-4754, XP001008625.
Sawyers CL., The New England Journal of Medicine, 340 (17): 1330-1340, 1999.
Vitale C, Romagnani C et al. Proc. Natl. Acd. Sci. USA, 96 (26): 15091-15096.
Vitale C et al., Proc. Natl. Acd. Sci. USA, 98 (10): 5764-5769, 2001.
Sievers El, Appelbaum FR et al. Blood, 93: 3678-3684, 1999.
Ito H et al., Bioorg. Med. Chem. 6(7): 1051-1056, 1998.
Tiyu G, Ftir, Vibrational Spectroscopy, vol. 24, No. 2, 225-231, 2000.
Fung VA, Mutation Research, vol. 204, No. 2, 219-228, 1988.
Y. Kuroda, Bio-antimutagenic acitivty of green tea catechins in cultured Chinese hamster V79 cells, Mutation Research, 361 pgs. 179-186 (1996).
A. Komori et al., “Anticarcinogenic Activity of Green Tea Polyphenols”, JPN, J Clin Oncol 23(3), pp. 186-190, (1993).
Bandyopadhyay Gautam
Bandyopadhyay Santu
Bhattacharya Samir
Chandra Pal Bikash
Chandra Roy Keshab
Council of Scientific and Industrial Research
Fitzpatrick ,Cella, Harper & Scinto
Padmanabhan Sreeni
Soroush Layla
LandOfFree
Synergistic composition for treating leukemia does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Synergistic composition for treating leukemia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Synergistic composition for treating leukemia will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4081434